XCXiaoming Cao

Xiaoming Cao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xiaoming Cao has a total of 61 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Comparative associations of six predefined dietary patterns with site-specific cancer risk in the UK Biobank

    by Long Gao, Pei Feng, Guofeng Shi, Yu Li, Bochen Ma, Chenqi Zhang, Yu Chen, Shaonan Li, Jingxi Hu, Liqiang Wang, et al.

    Background: Previous studies on diet and cancer have mainly examined individual dietary indices in relation to specific cancer outcomes, limiting direct comparison across dietary patterns. A unified population with consistent adjustment and standardized dietary-index scales is needed to explore whether different dietary patterns show different statistical associations with each specific cancer outcome. Methods: We included 118,056 cancer-free UK Biobank participants with at least two valid 24-h dietary assessments. Six predefined dietary indices were evaluated: DRLCD, aMED, AHEI-2010, DASH, CDAI, and E-DII. All indices were standardized to enable direct comparison. Progressively adjusted Cox regression models and 1-, 3-, and 5-year lagged sensitivity analyses were used as the primary analysis to identify the most stable diet–cancer outcome pairs. In the exploratory analysis, after excluding potential non-linear associations, standardized dietary indices were compared for colorectal, kidney, and lung cancers in the overall population and high genetic risk group to compare the direction and magnitude of associations across dietary patterns for each cancer outcome. Results: Eleven robust diet–cancer associations were identified. AHEI-2010 and DASH were inversely associated with colorectal cancer; AHEI-2010, aMED, CDAI, DASH, and reversed E-DII were inversely associated with kidney cancer; AHEI-2010, aMED, and reversed E-DII were inversely associated with lung cancer; and reversed E-DII was associated with lower overall cancer risk. DRLCD showed no robust association. In cross-index comparisons, the lowest HRs in the overall population were for DASH (colorectal cancer), reversed E-DII (kidney cancer), and AHEI-2010 (lung cancer); in the higher PRS group, they were for DASH (colorectal cancer), AHEI-2010 (kidney cancer), and reversed E-DII (lung cancer). However, bootstrap pairwise comparisons were not statistically significant, suggesting directional trends, not evidence of superiority. Conclusion: We identified significant and stable diet–cancer risk associations and observed differences in the direction or magnitude of associations across dietary indices. Because bootstrap pairwise comparisons were not statistically significant, these findings should be interpreted as directional trends and hypothesis-generating, not as evidence of a definitively optimal dietary strategy or dietary superiority.

  • Open Access

    Candidate plasma proteins associated with all-cause mortality among patients with prostate cancer: a UK biobank analysis

    by Long Gao, Yu Chen, Pei Feng, Chenqi Zhang, Jingxi Hu, Zhongyi Zheng, Guofeng Shi, Shaonan Li, Liqiang Wang, Xiaoting Yan, et al.

  • Open Access

    Preoperative prediction of pathological pelvic lymph node metastasis in prostate cancer using an elastic net model integrating clinicopathologic and 68Ga-PSMA PET/CT features: development and temporal validation

    by Yu Chen, Long Gao, Zhongyi Zheng, Pei Feng, Chenqi Zhang, Guofeng Shi, Shaonan Li, Jingxi Hu, Liqiang Wang, Bo Wu, et al.

    Preoperative decision-making regarding extended pelvic lymph node dissection (ePLND) in prostate cancer remains challenging. Existing nodal-risk prediction tools are mainly based on clinicopathologic variables and may show suboptimal performance across different clinical settings. This study aimed to develop and temporally validate a preoperative prediction model for pathological pelvic lymph node metastasis (pN1) by integrating clinicopathologic and 68Ga-PSMA PET/CT-derived features in a single-center Chinese surgical cohort. In this single-center retrospective study, consecutive patients with prostate cancer who underwent robot-assisted radical prostatectomy with ePLND and preoperative 68Ga-PSMA PET/CT were screened. Of 617 patients assessed for eligibility, 315 met the final analytic criteria. Patients treated from 2020 to 2024 formed the development cohort (n = 210), and patients treated in 2025 served as an independent temporal validation cohort (n = 105). Two elastic net regularized logistic regression models were developed using preoperative variables: a clinicopathologic model and an integrated model combining clinicopathologic and PSMA PET/CT-derived features. Internal robustness was assessed using 50 repeated stratified random splits of the development cohort. Final locked models were then applied, without re-tuning, to the temporal validation cohort. Model performance was evaluated using area under the receiver operating characteristic curve (AUC), calibration, Brier score, and decision curve analysis. The Memorial Sloan Kettering Cancer Center (MSKCC) model was evaluated as a benchmark. In the development cohort, 57/210 (27.1%) patients had pathologically confirmed pN1 disease, compared with 27/105 (25.7%) in the temporal validation cohort. Across 50 repeated stratified splits in the development cohort, the clinicopathologic model achieved a mean test AUC of 0.910 (SD 0.029), whereas the integrated model achieved a mean test AUC of 0.962 (SD 0.022). In the temporal validation cohort, the clinicopathologic model achieved an AUC of 0.877 (95% CI 0.799-0.955), whereas the integrated model achieved an AUC of 0.943 (95% CI 0.898-0.989). The integrated model showed sensitivity of 0.852, specificity of 0.897, negative predictive value of 0.946, accuracy of 0.886, and a Brier score of 0.080. Calibration was acceptable, with more favorable calibration for the integrated model than for the clinicopathologic model. Decision curve analysis showed greater net benefit for the integrated model than for both the clinicopathologic model and the MSKCC benchmark across most clinically relevant threshold probabilities. In this single-center Chinese surgical cohort, an elastic net model integrating clinicopathologic and 68Ga-PSMA PET/CT-derived features showed favorable performance for preoperative pN1 prediction, including in temporal validation. Compared with a clinicopathologic model alone and a locally implemented MSKCC benchmark, the integrated model showed more favorable discrimination and potential clinical utility. Multicenter external validation is required before broader clinical application.

  • Open Access

    Seven cases of robot-assisted radical cystectomy with Bordeaux neobladder: A clinical observation

    by Hua Yang, Xuchang Liu, Bo Wu, Jingjing Li, Yangjie Gao, Guochen Zhao, Wenjie Yang, Junyuan Bing, Xiaoming Cao

    Background: Bladder cancer (BCa) poses a significant global health burden with mounting incidence and mortality rates. Effective treatment strategies are urgently needed to alleviate the disease burden and improve patients’ quality of life (QoL). Objective: This study aimed to evaluate the efficacy of robot-assisted radical cystectomy (RARC) plus the Bordeaux robotic intracorporeal orthotopic neobladder (riONB) technique for the treatment of BCa. Methods: We retrospectively analyzed clinical data from seven male patients who had undergone RARC with Bordeaux riONB between June 2023 and November 2024. The median age was 68 years, and the median body mass index was 24.2 kg/m2. The study assessed their demographic data, intra- and post-operative parameters, pathological characteristics, and complications. Results: The median operation time lasted for 583 min, with a median estimated blood loss of 375 mL and a median post-operative hospital stay of 10 days. Pathological results showed that five patients (71.4%) were at stage ≥T2. According to the Clavien-Dindo classification, six patients (85.7%) had grade I – II complications. At 6 months post-surgery, the average maximum cystometric capacity measured 397 mL, the average post-void residual urine volume was 29 mL, the average urine flow rate was 5.6 mL/s, and the incontinence-QoL score was 85. Daytime urinary control was good in five patients (71.4%), and nighttime control was good in three patients (42.9%). Conclusion: The results indicate that RARC + Bordeaux riONB is a safe and effective surgical option for BCa, accomplishing good patient recovery and significant clinical efficacy. However, the study was subject to limitations of a small sample size and a short follow-up period. Further research with larger cohorts and longer follow-up is warranted to confirm these findings.

  • Mutational landscape and clinical implications of VHL in clear cell renal cell carcinoma: a multi-dataset analysis of 1377

    by Qiang Tian, Wenwen Tang, Xiaoming Cao

    Purpose Kidney cancer stands as a threat worldwide, with clear cell renal cell carcinoma (ccRCC) emerging as its predominant subtype. Through the establishment of extensive databases, the somatic mutations associated with ccRCC are successfully pinpointed. The tumor suppressor gene Von Hippel-Lindau (VHL) is commonly mutated in ccRCC. Objective In this study, we aim to analyze different cBIOPortal datasets to explore VHL mutation frequencies in ccRCC. Methods The datasets explored were Kidney Renal Clear Cell Carcinoma (TCGA, Nature 2013), Kidney Renal Clear Cell Carcinoma (IRC, Nat Genet 2014), Kidney Renal Clear Cell Carcinoma (TCGA, Firehose Legacy), Kidney Renal Clear Cell Carcinoma (TCGA, PanCancer Atlas). Data mining from various datasets revealed that VHL is the most mutated gene, with mutation frequencies of 79.5%, 51.2%, 49.9%, and 41.3% across different datasets: Kidney Renal Clear Cell Carcinoma (IRC, Nat Genet 2014), Kidney Renal Clear Cell Carcinoma (TCGA, Nature 2013), Kidney Renal Clear Cell Carcinoma (TCGA, Firehose Legacy), and Kidney Renal Clear Cell Carcinoma (TCGA, PanCancer Atlas), respectively. Results The mutated VHL gene is associated with significantly reduced overall survival (OS) rates based on the analyses of these datasets. VHL mutation becomes more advanced at a late age with many distant metastases. Conclusion This data confirms the mutational burden of VHL in ccRCC and suggests it is a potential therapeutic target for the management of ccRCC.


  • Open Access

    Analysis of risk factors for positive margins in robot-assisted laparoscopic radical prostatectomy with Retzius-sparing (RS-RARP)

    by Hua Yang, Bo Wu, Xuchang Liu, Kaiyuan Jia, Junyuan Bing, Yangjie Gao, Pengliang Shen, Xiaoming Cao

    This study aims to analyze the risk factors for positive surgical margins following robot-assisted laparoscopic radical prostatectomy with Retzius-sparing (RS-RARP) to provide a basis for clinical preoperative evaluation and intraoperative decision-making. A retrospective analysis was conducted on the clinical data of 103 patients who underwent RS-RARP at the First Hospital of Shanxi Medical University from May 2022 to May 2024. Patients were divided into positive margin and negative margin groups, as well as apical positive margin and apical negative margin groups based on surgical margin status. Patient demographics, preoperative data, and postoperative data were collected. Univariate and multivariate logistic regression analyses were used to evaluate the relationship between various factors and surgical margin status. A total of 103 patients were included, with 31 cases (30.1%) in the positive margin group and 72 cases (69.9%) in the negative margin group. The results of the Logistic Regression With Variable Reduction indicated that prostate volume (OR = 10.90, 95% CI: 3.49–34.04, p < 0.001) and ≥pT3 stage tumors (OR = 8.78, 95% CI: 2.54–30.42, p < 0.001) were independent risk factors for positive surgical margins. Additionally, they were also significantly associated with an increased risk of positive surgical margins at the prostate apex. The study indicates that prostate volume and pT stage are notable predictors of positive surgical margins in RS-RARP.

  • Open Access

    Arthritis increases the risk of prostate cancer: Results from the National Health and Nutrition Examination Survey 2005–2018 and two-sample Mendelian randomization analysis

    by Xiaobin Yuan, Ruikang Shi, Qiang Jing, Xiaoming Cao, Xuhui Zhang

    Yuan X, et al. Investig Clin Urol. 2025 Apr;66:e32. https://doi.org/10.4111/icu.20240313


  • Open Access

    Association of dietary live microbe intake with kidney stone disease in US adults: a real-world cross-sectional study

    by Zhongyi Zheng, Xiaoming Cao

    Background: Kidney stone disease (KSD) is a common urological condition linked with hypertension, chronic kidney disease, and other health issues. Although the gut microbiome has a notable association with KSD formation, the relationship between dietary live microbes and KSD risk remains underexplored.Methods: This study utilized data from the NHANES surveys conducted between 2007 and 2016 to analyze the association between dietary live microbe intake and KSD. Dietary intake data were obtained through 24-h dietary recall interviews conducted by trained professionals. Participants were categorized into three groups based on Sanders’ classification system of dietary live microbe intake: low, medium, and high. The intake levels were determined by estimating the live microbe content in foods. Weighted logistic regression analysis was employed to account for the complex survey design and to assess the impact of different levels of live microbe intake on KSD risk.Results: A total of 20,380 participants were included in the study. Participants with low, medium, and high dietary microbe intake represented 33, 39, and 28% of the cohort, respectively. The adjusted odds ratios (ORs) for KSD were 0.78 (95% CI, 0.65–0.93) in the high dietary live microbe group compared to the low group (p < 0.05). Subgroup analyses revealed no significant interactions between dietary live microbe intake and gender, age, BMI, hypertension, or diabetes status.Conclusion: Higher dietary live microbe intake group may be associated with a reduced risk of KSD. Further prospective studies are necessary to validate these findings and to elucidate the specific mechanisms and optimal intake levels of dietary microbes.


  • Open Access

    Impact of deep brain stimulation on urogenital function in Parkinson’s disease: a systematic review and meta-analysis

    by Long Gao, Meng Wang, Mengdi Zhou, Wenjuan Yin, Xiaoming Cao

    Objectives: Deep Brain Stimulation (DBS) effectively treats Parkinson’s motor symptoms, but its effects on the urogenital system are debated.Methods: A research was conducted in PubMed, Embase, Cochrane Library, Web of Science, and Scopus until February 27, 2024. We primarily focused on DBS’s impact on Parkinson’s patients’ Urine storage function, voiding function, sexual function, and quality of life.Results: Our meta-analysis included 14 studies. The main results showed that DBS resulted in fewer instances of urinary urgency (OR = 1.85, 95% CI: 1.26 to 2.70, p = 0.002) and increased maximum bladder capacity (MD = −66.10, 95% CI: −119.37 to −12.82, p = 0.02) in terms of urinary storage function. However, there were no significant differences in first desire to void and strong desire to void. In terms of voiding function, DBS showed significant improvements in maximum flow rate (MD = −0.64, 95% CI: −1.23 to −0.05, p = 0.03), post-void residual (MD = −6.79, 95% CI: 4.54 to 9.05, P < 0.00001) and detrusor pressure during maximum flow (MD = −1.37, 95% CI: −2.73 to −0.02, p = 0.05). Additionally, there was no significant difference in sexual function between the two groups (MD = −1.41, 95% CI: −12.40 to 9.57, p = 0.80).Conclusion: DBS has demonstrated a certain degree of efficacy in ameliorating urinary storage and voiding function in patients with Parkinson’s disease. However, certain urodynamic parameters or scores do not demonstrate any statistically significant disparities. Furthermore, DBS has no significant impact on erectile function in male Parkinson’s patients.Systematic review registration: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023476661, identifier CRD42023476661.


  • Open Access

    Network meta-analysis of treatments for perineal extramammary paget’s disease: Focusing on performance of recurrence prevention

    by Xiaobin Yuan, Ruizhi Xue, Xiaoming Cao

    Introduction: Perineal extramammary paget’s disease (EMPD) is characterized with high recurrence rate. Although numerous therapeutic measures for this disease have been reported so far, it is unknown whether there is significant difference in their recurrence-preventing efficiency. This study aims to compare the recurrence outcomes of reported perineal EMPD treatments. Methods: We searched public databases of for published studies concerning perineal EMPD treatments. After screening by inclusion and exclusion criteria, we extracted the data relevant to recurrence rate, and conducted network meta-analysis (NMA) by using Bayesian random-effects approach. Results: Our analysis included 29 previous studies (involving both male and female patients) and 11 treatment designs which are wide local excision (WLE), local excision (LE), Mohs micrographic surgery (MMS), radiotherapy (RT), radical vulvectomy (RV), photodynamic therapy (PDT), lasers (LS), imiquimod, and WLE+RT, WLE+PDT, WLE+LS. Comparing with WLE, the MMS showed significant advantage in reducing recurrence [OR: 0.18 (0.03–0.87)], while none of the rest treatments has statistically significant results. After removing outlier studies, MMS still has the significant advantages [OR: 0.35 (0.11–0.82)], and LE turned to be the treatment with worst performance [OR: 13 (2.50–110)]. Covariance analysis of follow-up length, gender differences, and lesion locations indicated only short follow-up time could affect the recurrence statistics, which tend to conceal the real differences. Funnel plot demonstrated there is no significant small study effect. Conclusion: MMS has the best performance on reducing perineal EMPD recurrence, while LE exhibits the worst capability in such regard. Recurrence-preventing abilities of other treatments have no significant difference between each other.